Ideal Customers Target cataract surgery programs and ophthalmic centers seeking advanced accommodating IOLs. Highlight how Adaptilens restores accommodation to reduce glasses dependence and improve patient satisfaction, making it attractive to hospitals and ambulatory surgery centers.

Channel Partnerships Given the lean team and successful Series A, pursue partnerships with established ophthalmic distributors, contract manufacturers, and device OEMs to scale manufacturing, regulatory support, and sales reach; consider licensing or co-development opportunities to accelerate adoption.

Clinical Validation Accelerate clinical and preclinical validation through investor-backed funding by producing compelling case studies and clinical data. Engage key opinion leaders to validate performance and safety, enabling faster payer and hospital adoption.

Regional Focus Leverge Boston area exposure to access top teaching hospitals and academic centers; target Northeast networks first, with expansion to national and international markets through strategic partnerships and channel partners.

Differentiation Edge Differentiate from traditional IOLs by offering true accommodation responsiveness. Craft value narrative around patient independence, long-term costs, and workflow efficiency to appeal to surgeons, hospitals, and payers.